Emily LNG IUS | The Contraceptive Pipeline Database

Product Overview

Development Status: Limited Market Approval

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: Emily is the name under which HLL Lifecare Limited markets a LNG IUS in India. It consists of a M-shaped polyethylene frame with a steroid reservoir containing 52 mg levonorgestrel held within an inserter tube. Also marketed for treatment of heavy menstrual bleeding.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): levonorgestrel

Inactive material: Silicone rubber, LDPE plastic frame

Potential Multi-Purpose Technology (MPT): No

Regimen: Single insertion

Duration: 5 years

Dose: 20 µg per day

Partner: HLL Lifecare Limited, Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)

Status

Project Phase: Post-development

Project Stage: Marketed

Began discovery in: 2006

Status Details:
Approved in India in 2011; it was introduced for use in 2012.

Programmatic Considerations

Additional Information

Additional Information:
Product website

Gopimohan R, Chandran A, et al. (2015) A clinical study assessing the efficacy of a new variant of the levonorgestrel intrauterine system for abnormal uterine bleeding. Int J Gynaecol Obstet. 129(2):114-7.

Download Product Report